Peroxisome proliferator-activated receptor γ activators inhibit interleukin-1β-induced nitric oxide and matrix metalloproteinase 13 production in human chondrocytes

Arthritis and Rheumatism

Volumn 44, Issue 3, 2001, Pages 595-607

  Fahmi, Hassan ^a,b   Di Battista, John A ^a,b   Pelletier, Jean Pierre ^a,b   Mineau, Franois ^a,b   Ranger, Pierre ^a,b   Martel Pelletier, Johanne ^a,b  

^a NOTRE DAME HOSPITAL   (Canada)

^b Hpital Sacr Coeur   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGENASE 3; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 17; INTERLEUKIN 1BETA; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR AGONIST; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROSTAGLANDIN DERIVATIVE; ROSIGLITAZONE; TRANSCRIPTION FACTOR AP 1; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CARTILAGE CELL; CONTROLLED STUDY; DOSE RESPONSE; ENZYME SYNTHESIS; EXPRESSION VECTOR; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; REPORTER GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

CHONDROCYTES; COLLAGENASES; ENZYME ACTIVATION; HUMANS; INTERLEUKIN-1; MAP KINASE KINASE KINASE 1; MATRIX METALLOPROTEINASE 13; NF-KAPPA B; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; PROMOTER REGIONS (GENETICS); PROSTAGLANDIN D2; PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RNA, MESSENGER; TRANSCRIPTION FACTOR AP-1; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

EID: 0035083913     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/1529-0131(200103)44:3<595::AID-ANR108>3.0.CO;2-8     Document Type: Article

References (62)

1. Acceleration of onset of collagen-induced arthritis by intraarticular injection of tumour necrosis factor or transforming growth factor-beta
2. Arthritogenic actions of recombinant IL-1 and tumour necrosis factor alpha in the rabbit: Evidence for synergistic interactions between cytokines in vivo
3. Etiopathogenesis of osteoarthritis
4. Nitric oxide production and inducible nitric oxide synthase expression in inflammatory arthritides
5. Imbalance between interstitial collagenase and tissue inhibitor of metalloproteinases 1 in synoviocytes and fibroblasts upon direct contact with stimulated T lymphocytes: Involvement of membrane-associated cytokines
6. Increased concentrations of nitrite in synovial fluid and serum samples suggest increased nitric oxide synthesis in rheumatic diseases
7. Reduction in the structural changes of experimental osteoarthritis by a nitric oxide inhibitor
8. Selective inhibition of inducible nitric oxide synthase in experimental osteoarthritis is associated with reduction in tissue levels of catabolic factors
9. Suppression of adjuvant-induced arthritis by selective inhibition of inducible nitric oxide synthase
10. The role of nitric oxide in inflammation and immunity
11. Mechanisms of chondrocyte apoptosis
12. The increased synthesis of inducible nitric oxide inhibits IL-1ra synthesis by human articular chondrocytes: Possible role in osteoarthritic cartilage degradation
13. Collagenase-3 (MMP-13) is expressed during human fetal ossification and re-expressed in postnatal bone re-modeling and in rheumatoid arthritis
14. The new collagenase, collagenase-3, is expressed and synthesized by human chondrocytes but not by synoviocytes: A role in osteoarthritis
15. Biochemical characterization of human collagenase-3
16. Peroxisome proliferator-activated receptors: A nuclear receptor signaling pathway in lipid physiology
17. PPAR-gamma: Adipogenic regulator and thiazolidinedione receptor
18. Fatty acids, eicosanoids, and hypolipidemic agents identified as ligands of peroxisome proliferator-activated receptors by coactivator-dependent receptor ligand assay
19. A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation
20. An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma)
21. PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines
22. The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation
23. Isolation of the human peroxisome proliferator activated receptor gamma cDNA: Expression in hematopoietic cells and chromosomal mapping
24. The nuclear receptor PPARγ and immuno-regulation: PPAR γ mediates inhibition of helper T cell responses
25. Evidence for the presence of peroxisome proliferator-activated receptor (PPAR) alpha and gamma and retinoid Z receptor in cartilage: PPARgamma activation modulates the effects of interleukin-1beta on rat chondrocytes
26. Inhibition of inducible nitric oxide synthase by peroxisome proliferator-activated receptor agonists: Correlation with induction of heme oxygenase 1
27. Macrophages in human atheroma contain PPARgamma: Differentiation-dependent peroxisomal proliferator-activated receptor gamma (PPARgamma) expression and reduction of MMP-9 activity through PPARgamma activation in mononuclear phagocytes in vitro
28. A novel therapy for colitis utilizing PPAR-γ ligands to inhibit the epithelial inflammatory response
29. Mitogen-activated protein kinase and nuclear factor κB together regulate interleukin-17-induced nitric oxide production in human osteoarthritic chondrocytes: Possible role of transactivating factor mitogen-activated protein kinase-activated protein kinase (MAPKAPK)
30. Collagenase-3 (matrix metalloprotease 13) is preferentially localized in the deep layer of human arthritic cartilage in situ: In vitro mimicking effect by transforming growth factor β
31. Cloning, sequencing and characterization of the 5′-flanking region of the human collagenase-3 gene
32. Transcriptional regulation of human inducible nitric oxide synthase (NOS2) gene by cytokines: Initial analysis of the human NOS2 promoter
33. Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors alpha and gamma
34. Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids
35. Signaling by proinflammatory cytokines: Oligomerization of TRAF2 and TRAF6 is sufficient for JNK and IKK activation and target gene induction via an amino-terminal effector domain
36. Coordinate regulation of IκB kinases by mitogen-activated protein kinase kinase kinase 1 and NF-κB-inducing kinase
37. Activation of stress-activated protein kinase by MEKK1 phosphorylation of its activator SEK1
38. Role of MEKK1 in cell survival and activation of JNK and ERK pathways defined by targeted gene disruption
39. Identification of a dual specificity kinase that activates the Jun kinases and p38-Mpk2
40. Multiple NF-kappaB enhancer elements regulate cytokine induction of the human inducible nitric oxide synthase gene
41. Structural analysis and promoter characterization of the human collagenase-3 gene (MMP13)
42. Differential effects of transforming growth factor-beta on the expression of collagenase-1 and collagenase-3 in human fibroblasts
43. Peroxisome proliferator-activated receptors alpha and gamma are activated by indomethacin and other non-steroidal anti-inflammatory drugs
44. Differential activation of peroxisome proliferator-activated receptors by eicosanoids
45. Effect of an enteric-coated fish-oil preparation on relapses in Crohn's disease
46. Effects of fish oil supplementation on non-steroidal anti-inflammatory drug requirement in patients with mild rheumatoid arthritis - A double-blind placebo controlled study
47. The PPARα-leukotriene B4 pathway to inflammation control
48. Activation of human aortic smooth-muscle cells is inhibited by PPARα but not by PPARγ activators
49. Cyclopentenone prostaglandins suppress activation of microglia: Down-regulation of inducible nitric-oxide synthase by 15-deoxy-Δ12,14-prostaglandin J2
50. Differential regulation of IkappaB kinase alpha and beta by two upstream kinases, NF-kappaB-inducing kinase and mitogen-activated protein kinase/ERK kinase kinase-1
51. The NF-kappa B and I kappa B proteins: New discoveries and insights
52. AP-1 function and regulation
53. A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors
54. Steroid receptor coactivator-1 coactivates activating protein-1-mediated transactivations through interaction with the c-Jun and c-Fos subunits
55. CREB-binding protein/p300 are transcriptional coactivators of p65
56. Steroid receptor coactivator-1 interacts with the p50 subunit and coactivates nuclear factor kappaB-mediated transactivations
57. An update on the mechanisms of action of the peroxisome proliferator-activated receptors (PPARs) and their roles in inflammation and cancer
58. Occurrence of 9-deoxy-delta 9,delta 12-13,14-dihydroprostaglandin D2 in human urine
59. 9-Deoxy-delta 9, delta 12-13,14-dihydroprostaglandin D2, a metabolite of prostaglandin D2 formed in human plasma
60. Differences in the production of arachidonic acid metabolites between healthy and rheumatic synovial fibroblasts in vitro: A preliminary study
61. Human synovial mast cells. II. Heterogeneity of the pharmacologic effects of antiinflammatory and immunosuppressive drugs
62. Inducible cyclooxygenase may have antiinflammatory properties